Vise Technologies Inc. Makes New $1.30 Million Investment in Agilent Technologies, Inc. $A

Vise Technologies Inc. bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the second quarter, HoldingsChannel.com reports. The firm bought 9,821 shares of the medical research company’s stock, valued at approximately $1,304,000.

Several other hedge funds and other institutional investors also recently modified their holdings of A. Norges Bank bought a new stake in shares of Agilent Technologies during the 4th quarter worth $549,158,000. Bank of New York Mellon Corp lifted its holdings in shares of Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after acquiring an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Finally, Deutsche Bank AG grew its holdings in shares of Agilent Technologies by 17.1% during the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after purchasing an additional 1,024,516 shares during the last quarter.

Agilent Technologies Stock Performance

NYSE A opened at $159.25 on Friday. The company has a market capitalization of $44.98 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 2.81 and a beta of 1.25. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The stock has a fifty day simple moving average of $137.57 and a 200 day simple moving average of $126.23. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on A shares. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective for the company. Morgan Stanley increased their price target on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Sanford C. Bernstein began coverage on Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price objective on the stock. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their target price for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Finally, Piper Sandler started coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.